Pathological fracture due to malignant neoplasm

https://doi.org/10.53730/ijhs.v6nS6.11413

Authors

  • Arvind Kumar Assistant Professor, Department of Orthopaedics, Patna Medical College, Patna (Bihar)
  • Usha Singh Consultant Radiation oncology, Mahavir Cancer Sansthan, Phulwarisharif, Patna, Bihar

Keywords:

pathological fracture, metastatic bone disease, internal fixation

Abstract

Pathological fractures can be caused by any type of bone tumor, but the majority of pathologic fractures in the elderly are secondary to metastatic carcinomas. Multiple myeloma is also common in the elderly and has a high incidence of pathologic fractures. The surgical treatment of impending or pathologic fracture are to provide pain relief and a functionally stable and durable construct that will allow the patient to ambulate shortly after surgery. Fixation of metastatic pathologic fractures requires reinforcement or replacement of the compromised bone with a rigid and durable construct. Aim of the study-is to evaluate pathological fracture in metastatic disease of bone fromdifferent type of malignancy. Material and methods-This is a retrospective analysis of 50 patients of histopathologically proven metastatic bone disease, evaluated for pathological fracture in Mahavir Cancer Sansthan during 2014-2016. Results-Out of 50 patients of metastatic bone disease 13 (26%) patients had pathological fracture.Maximum numbers of patients 6(46.1%) belongs to age range of 50-59 years. Out of 13 patients, 7(53.8%) were male 6(46.1%) patients were female. 

Downloads

Download data is not yet available.

References

Brihaye J, Ectors P, Lemort M. The management of spinal epidural metastases. Adv TechStandNeurosurg1988;16:121–176.

Buggay D, Jaffe K. Metastatic bone tumors of the pelvis and lower extremity. J SurgOrthopAdv2003;12:192–9

Campanacci, M. Bone and Soft Tissue Tumors. New York: Springer-Verlag, 1999.

Cheng EY. Prospective quality of life research in bony metastatic disease.ClinOrthop. 2003;415(Suppl):289-97.

Coleman RE. Skeletal complications of malignancy. Cancer 1997;80:1588–94.

Croucher, PI. Bone Disease in Multiple Myeloma. Br Jour of Haematology 1998; 103:902-910.

Douglas Kenji et al .Prognostic factor in pathological fracture seen in metastatic tumor.2006;61(4):313-20.

Friedl W, Mieck U, Fritz T. Surgical therapy of bone metastasesof the upper and lower extremity. Chirurg. 1992;63:897-911.

Friedl W. Indication, management and results of surgicaltherapy for pathological fractures in patients with bone metastases.Eur J SurgOncol. 1990;16:380-96.

Graupe F, Heitmann C, Becker M, et al. Palliative surgicaltreatment of bone metastases. Improved quality of life by earlyintervention? Dtsch Med Wochenschr. 1996;121:393-7.

Harrington KD. Metastatic disease of the spine. In: Harrington KD, ed. Orthopaedic managementof metastatic bone disease. St. Louis: Mosby, 1988:309–383.

Kay PR. Cement augmentation of pathological fracture fixation.J Bone Joint Surg Br. 1989;71:702.

Melton LJ, Kyle RA, Achenbach SJ. Fracture risk with multiple myeloma: a population-basedstudy. J Bone Miner Res 2005;20:487–493

Mercadante S. Malignant bone pain: pathophysiology andtreatment. Pain. 1997;69:1-18.

Mirels H. Metastatic disease in long bones. A proposed scoring system for diagnosingimpending pathologic fractures. ClinOrthopRelat Res 1989;(249):256–264.

Mukhtar, A. U. S., Budu, B., Sanusi B, Y., Mappawere, N. A., & Azniah, A. (2022). The effect of reproductive health education with multimedia video learning on the improvement of fluor albus prevention behavior young woman pathologist. International Journal of Health & Medical Sciences, 5(1), 75-79. https://doi.org/10.21744/ijhms.v5n1.1841

Mundy GR. Mechanisms of bone metastasis. Cancer. 1997;80:1546-56.

Reich CD. Advances in the treatment of bone metastases. Clin J OncolNursing. 2003;7:641-6.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Swanson KC, Pritchard DJ, Sim FH. Surgical treatment of metastaticdisease of the femur. J Am AcadOrthop Surg. 2000;8:56-65.

Ward WG, Holsenbeck S, Dorey FJ. Metastatic disease of the femur: surgical treatment. ClinOrthopRelat Res 2003;(415 Suppl):S230–S244.

Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and theimpostors. Spine 1990;15:1–4.

Published

01-08-2022

How to Cite

Kumar, A., & Singh, U. (2022). Pathological fracture due to malignant neoplasm. International Journal of Health Sciences, 6(S6), 7613–7623. https://doi.org/10.53730/ijhs.v6nS6.11413

Issue

Section

Peer Review Articles

Most read articles by the same author(s)